Limited oxygen delivery to tissues (hypoxia) is common in a variety of disease states. A number of parallels exist between hypoxia and acute inflammation, including the observation that both influence vascular permeability. As such, we compared the functional influence of activated polymorphonuclear leukocytes (PMN) on normoxic and posthypoxic endothelial cells. Initial studies indicated that activated PMN preferentially promote endothelial barrier function in posthypoxic endothelial cells (>60% increase over normoxia). Extension of these findings identified at least one soluble mediator as extracellular adenosine triphosphate (ATP). Subsequent studies revealed that ATP is coordinately hydrolyzed to adenosine at the endothelial cell surface by hypoxia-induced CD39 and CD73 (>20-and >12-fold increase in mRNA, respectively). Studies in vitro and in cd39-null mice identified these surface ecto-enzymes as critical control points for posthypoxia-associated protection of vascular permeability. Furthermore, insight gained through microarray analysis revealed that the adenosine A2B receptor (AdoRA2B) is selectively up-regulated by hypoxia (>5-fold increase in mRNA), and that AdoRA2B antagonists effectively neutralize ATP-mediated changes in posthypoxic endothelial permeability. Taken together, these results demonstrate transcription coordination of adenine nucleotide and nucleoside signaling at the vascular interface during hypoxia.
Skip Nav Destination
Article navigation
1 September 2003
Article|
August 25 2003
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium : Role of Ectonucleotidases and Adenosine A2B Receptors
Holger K. Eltzschig,
Holger K. Eltzschig
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital
7Department of Anesthesiology and Intensive Care Medicine, Eberhard-Karls-University, D-72076 Tübingen, Germany
Search for other works by this author on:
Juan C. Ibla,
Juan C. Ibla
2Department of Anesthesiology, Perioperative and Pain Medicine
Search for other works by this author on:
Glenn T. Furuta,
Glenn T. Furuta
3Combined Program for Pediatric Gastroenterology and Nutrition, Children's Hospital, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Martin O. Leonard,
Martin O. Leonard
4The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other works by this author on:
Kenneth A. Jacobson,
Kenneth A. Jacobson
5Molecular Recognition Section, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Keiichi Enjyoji,
Keiichi Enjyoji
6Transplantation Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Simon C. Robson,
Simon C. Robson
6Transplantation Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Sean P. Colgan
Sean P. Colgan
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital
Search for other works by this author on:
Holger K. Eltzschig
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital
7Department of Anesthesiology and Intensive Care Medicine, Eberhard-Karls-University, D-72076 Tübingen, Germany
Juan C. Ibla
2Department of Anesthesiology, Perioperative and Pain Medicine
Glenn T. Furuta
3Combined Program for Pediatric Gastroenterology and Nutrition, Children's Hospital, Harvard Medical School, Boston, MA 02115
Martin O. Leonard
4The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Kenneth A. Jacobson
5Molecular Recognition Section, National Institutes of Health, Bethesda, MD 20892
Keiichi Enjyoji
6Transplantation Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
Simon C. Robson
6Transplantation Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
Sean P. Colgan
1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital
Address correspondence to Sean P. Colgan, Ph.D., Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Thorn Building 704, 75 Francis St., Boston, MA 02115. Phone: (617) 278-0599 ext. 1401; Fax: (617) 278-6957; email: [email protected]
Abbreviations used in this paper: AdoRA2B, adenosine A2B-receptor; HIF-1, hypoxia-inducible factor-1.
Received:
June 03 2003
Revision Received:
July 15 2003
Accepted:
July 15 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (5): 783–796.
Article history
Received:
June 03 2003
Revision Received:
July 15 2003
Accepted:
July 15 2003
Citation
Holger K. Eltzschig, Juan C. Ibla, Glenn T. Furuta, Martin O. Leonard, Kenneth A. Jacobson, Keiichi Enjyoji, Simon C. Robson, Sean P. Colgan; Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium : Role of Ectonucleotidases and Adenosine A2B Receptors . J Exp Med 1 September 2003; 198 (5): 783–796. doi: https://doi.org/10.1084/jem.20030891
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement